Answers are grounded in this paper and cite their sources.
The study highlighted benefits of semaglutide on metabolic control, multiple CV risk factors, and renal safety in the real-world. Semaglutide seems to be an advisable option for preservation of β-cell function and early evidence suggests it might have a role in modifying insulin resistance (HOMA-IR), the pathogenetic basis of prediabetes and T2D.
No takes yet. Share an insight, caveat, or question.
Berra et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: